Seeking Alpha
View as an RSS Feed

Bret Jensen  

View Bret Jensen's Comments BY TICKER:
A, AA, AAPL, ABB, ABT, ABTL, ABX, ACLS, ACMP, ACTG, ACTV, ADBE, ADSK, AEP, AGCO, AGEN, AGU, AHH, AHT, AIG, AKS, ALJ, ALL, ALR, AMAT, AMGN, AMKR, AMTD, AMZG, AMZN, ANF, ANV, APA, APC, APL, ARCP, ARII, ARLP, ARO, ARP, ATRS, ATSG, ATVI, ATW, AU, AVGO, AVNR, AXAS, AXTI, AYR, AZN, BA, BAC, BAS, BAX, BBBY, BBEP, BBRY, BBT, BBW, BBY, BCEI, BGFV, BHI, BIDU, BIG, BIIB, BIOL, BK, BKCC, BKH, BKW, BLK, BMO, BMR, BNS, BP, BRCD, BRCM, BRKS, BTU, BWP, BX, BYI, C, CALL, CAT, CBI, CBOU, CDE, CELG, CEO, CERS, CGIX, CGR, CHK, CHL, CHMT, CJES, CLDT, CLF, CLMT, CLR, CMG, CMI, CMLP, CNAT, CNDO, CNP, CNQ, CNX, COF, COG, COH, COOL, COP, CORT, CPE, CPIX, CPSI, CRM, CROX, CRUS, CRZO, CSCO, CSX, CTCM, CVE, CVS, CVX, CXPO, CXS, CY, DAKT, DAN, DBC, DD, DDE, DECK, DENN, DG, DISH, DK, DNR, DO, DOW, DRH, DRIV, DSCO, DTLK, DTV, DUSA, DVAX, DVN, DVR, DWA, DXLG, E, EBAY, ECA, EDR, ELLI, ELY, EMC, END, ENDP, EOG, EOX, EPAM, EPAX, EPB, EPR, EQIX, EQM, EROC, ESIO, ESV, ETE, ETN, ETP, ETRM, EVEP, EWZ, EXK, EXLP, EXPE, EXXI, F, FANG, FB, FCH, FCX, FDX, FIG, FLL, FLY, FOLD, FOSL, FRD, FSC, FSII, FURX, FWLT, FXCM, GBX, GCOM, GE, GEF, GEOY, GERN, GES, GEVA, GFI, GILD, GLP, GLUU, GLW, GM, GNW, GOOG, GOOGL, GPOR, GPS, GS, GSK, GSM, GSS, GTATQ, GTE, HAL, HBM, HCBK, HCLP, HEP, HERO, HES, HFC, HIG, HL, HLF, HLX, HMA, HON, HOS, HP, HPQ, HPT, HRS, HRZN, HTA, HTGC, HURN, HZNP, IACI, IAG, IGTE, IMOS, INN, INT, INTC, INVN, IO, IPGP, IQNT, IRDM, IRET, IRT, ISRG, ITRI, ITT, IVAN, JAZZ, JDSU, JNJ, JNPR, JOY, JPM, KBH, KBR, KCG, KEG, KERX, KFY, KKR, KLAC, KLIC, KO, KOG, KONA, KR, KRG, KRO, LAD, LCI, LGCY, LIFE, LIME, LINE, LLL, LLNW, LLY, LMOS, LMT, LNCO, LNKD, LO, LOCO, LOW, LPRI, LSI, LUK, LULU, LVS, LXP, LYB, M, MANT, MCEP, MCHX, MCP, MDR, MDT, MELI, MEMP, MET, MHR, MITL, MMLP, MMP, MNK, MO, MOD, MOS, MPC, MPO, MPW, MRCY, MRGE, MRK, MRO, MRVL, MS, MSFT, MT, MTDR, MTOR, MTSN, MU, MUR, MXIM, MYL, MYRG, NAVB, NBL, NBR, NE, NEE, NEM, NEON, NFLX, NFX, NGLS, NGPC, NILE, NOG, NOK, NOV, NSC, NSPH, NTAP, NTSP, NUAN, NVAX, NVDA, NVS, NWY, NXPI, NYCB, NYX, OAS, OCN, OCZ, OHI, OIS, OKS, OPEN, OPLK, ORAN, ORCL, ORIG, ORLY, OUTR, OVTI, OXY, OZM, PAA, PAAS, PACD, PACR, PANW, PAYX, PBF, PBH, PBI, PBY, PCLN, PDH, PDLI, PDS, PEET, PEG, PES, PETM, PETS, PFE, PFMT, PGEM, PH, PM, PNG, PNK, PNRA, POM, POT, PRTA, PSX, PTEN, PULB, PVR, PWER, QCCO, QCOM, QLGC, QLTY, QRE, QUMU, R, RAIL, RAX, RCL, RDWR, REGN, RES, REXX, RF, RFMD, RIG, RIGL, RIO, RNN, ROC, ROSE, ROVI, RPRX, RRD, RSTI, RTEC, RTN, RUE, RUTH, RVBD, SAM, SARA, SBRA, SCLN, SCMR, SCO, SDRL, SEAC, SFY, SHOR, SIGA, SIMG, SIMO, SIRI, SKUL, SLB, SLCA, SM, SMCI, SN, SNH, SNY, SODA, SPLK, SPLS, SPN, SPPI, SPRT, SPY, SQNM, SSH, SSNLF, STI, STJ, STMP, STO, STT, STX, SUNE, SVU, SWFT, SWKS, SYNA, SYRG, T, TAL, TAP, TBT, TCAP, TDW, TEF, TER, TESO, TEVA, TEX, TGX, TICC, TIVO, TKR, TLLP, TOT, TPC, TPLM, TQNT, TRLG, TRN, TSLA, TSO, TST, TSYS, TTI, TWI, TWX, UA, UNH, UNIS, UPL, USB, V, VALE, VELTF, VICL, VLO, VMW, VNR, VOD, VRA, VXX, VZ, WAC, WAG, WDC, WEN, WFC, WFT, WHR, WIFI, WLL, WMT, WRES, XEC, XOM, XRX, YELP, YHOO, Z, ZAGG, ZEUS, ZIXI, ZLTQ, ZNGA
Latest  |  Highest rated
  • 10% Correction Feels Imminent [View article]
    Have seen this in Miami especially in construction which is almost all manned by illegals. I understand completely wanting to go somewhere to make better money to send home to family back home. However, it is hard for the working blue collar native to compete against five men living in one room willing to do what had been a $25 to $35 a hour job for $10 a hour.
    Jul 22, 2015. 05:51 AM | 5 Likes Like |Link to Comment
  • Celgene: New Deals Creating More Compelling Investment Case [View article]
    Wish I would have sold it at around $13 after buying it at $3.50 or so. Depomed acquisition would be a positive.
    Jul 21, 2015. 02:03 PM | Likes Like |Link to Comment
  • Why I Bought This $5 Busted IPO That Cramer Is No Longer Touting [View article]
    Zeltiq Aesthetics (ZLTQ -1%) initiated with Overweight rating and $35 (13% upside) price target by Piper Jaffray.
    Jul 21, 2015. 11:13 AM | Likes Like |Link to Comment
  • 8 Reasons To Buy This $1.30 Lottery Ticket [View article]
    $NVAX,,,,now a ten bagger since article.

    Top-line data from a Phase 1 trial show Novavax's (NASDAQ:NVAX) Ebola glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with the company's Matrix-M was well-tolerated and highly immunogenic in a group of 230 healthy adult volunteers. The results were presented during the World Health Organization's Fifth Teleconference on Ebola Vaccine Clinical Trials.
    Participants received either one or two intramuscular injections, with and without Matrix-M, ranging from 6.5 micrograms to 50 micrograms of antigen on study days 0 and 21. Immunogenicity was assessed at multiple times including days 28 and 35. The adjuvanted two-dose regimens induced Ebola anti-GP antibody increases of 500- to 750-fold over baseline at day 35. The adjuvanted single dose regimen induced increases of 21- to 27-fold over the same time frame.
    President & CEO Stanley Erck says, "These positive data represent the third time Novavax has leveraged the power of our platform technology to rapidly address an emerging threat. These Ebola GP Vaccine date, in combination with clinical data from our H7N9 VLP vaccine candidate and preclinical data from our vaccine candidate for Middle East Respiratory Syndrome coronavirus, provide additional validation of our nanoparticle vaccine platform."
    Jul 21, 2015. 10:56 AM | Likes Like |Link to Comment
  • Agenus: Even After Rally; Shares Still Have Upside [View article]
    Agenus (NASDAQ:AGEN) acquires the exclusive worldwide rights to antibodies targeting Carcinoembryonic Antigen Cell Adhesion Molecule 1 (CEACAM1), an immune checkpoint modulator, from Italian biotech Diatheva s.r.l. CEACAM1, a glycoprotein expressed in T cell and NK (natural killer) lymphocytes, is overexpressed in lung, colon, pancreatic and gastric cancers as well as melanoma. It has been shown to modulate innate and adaptive immune suppression in preclinical studies.Agenus is responsible for an upfront payment and additional milestones totaling as much as $44M. Diatheva is also eligible to receive royalties on commercial sales.
    Jul 20, 2015. 08:26 AM | 1 Like Like |Link to Comment
  • Celgene: New Deals Creating More Compelling Investment Case [View article]
    Don't know if explosion is right word, but we are overdue at least for a good correction. Small biotechs will take the brunt of it when it comes...large cap plays with real earnings and decent valuations like CELG and GILD will be less impacted. JMTC.
    Jul 19, 2015. 01:05 PM | Likes Like |Link to Comment
  • Celgene: New Deals Creating More Compelling Investment Case [View article]
    Does validate technology but CAR-T stocks have had huge run over last year.
    Jul 19, 2015. 01:03 PM | Likes Like |Link to Comment
  • Greenbrier Crushes Expectations, Stock Set To Move Higher [View article]
    Their backlog went down 900 cars in last quarter....only 45,100 cars in order backlog now........hardly any reason to panic for years.
    Jul 18, 2015. 09:45 PM | 2 Likes Like |Link to Comment
  • Bailing Out Of Brazil [View article]
    Thanks for the kind words. Glad you got this winner.
    Jul 18, 2015. 09:37 PM | Likes Like |Link to Comment
  • Bailing Out Of Brazil [View article]
    Brazil's political crisis deepens as Eduardo Cunha, the head of Brazil’s lower house, said today he is breaking with the ruling coalition.Cunha accused Pres. Rousseff's administration of pressuring prosecutors to implicate him in the widening corruption scandal at Petrobras scheme; late yesterday, the federal judge leading the investigation broadcast testimony from a defendant who turned state’s evidence alleging that Cunha took bribes.The move comes after a series of recent defeats in congress for Rousseff as lawmakers turned aside efforts to contain spending and raise taxes as she seeks to preserve Brazil’s investment-grade credit rating.PBR -5.5%, VALE -2.2%, EBR -2.1%, ELP -2.9%, CIG -5.8%, CPL -2.1%, SBS -2.9%, BSBR -1.1%, BBD -2.2%, ITUB -1.5%.
    Jul 17, 2015. 04:10 PM | 1 Like Like |Link to Comment
  • Zogenix: Promising Small Cap Biotech Is Breaking Out [View article]
    I have read your post history. You seem to love being a troll on myriad articles here on SA and can't even take a minute to create a bio, so not worth responding to.
    Jul 17, 2015. 10:23 AM | 4 Likes Like |Link to Comment
  • Acquisition Boosts AbbVie's Long Term Prospects [View article]
    The FDA designates AbbVie's (ABBV) investigational ABBV-8E12 an Orphan Drug for the treatment of progressive supranuclear palsy (PSP), a progressive neurodegenerative disorder that affects ~20K Americans. A Phase 1 study in PSP is underway.ABBV-8E12 is a recombinant humanized anti-tau antibody that binds to the tau protein found in neurofibrillary tangles in the brain of patients with PSP and Alzheimer's. Tau proteins, found mostly in neurons, stabilize microtubules, the architectural struts of nerve cells. The misfolding (mutation) of tau proteins contributes to progressive neuron loss.AbbVie acquired the license to the product candidate from discoverer C2N Diagnostics in March.PSP, also called Steele-Richardson-Olsz... syndrome, is characterized by dysfunction in walking, balance and eye movements caused by the deterioration of certain brain cells.
    Jul 17, 2015. 10:21 AM | 1 Like Like |Link to Comment
  • Zogenix: Promising Small Cap Biotech Is Breaking Out [View article]
    You certainly have gotten better of argument given recent stock market action so far as have I. Time will tell.
    Jul 17, 2015. 05:42 AM | Likes Like |Link to Comment
  • My Second Half Predictions - Part I [View article]
    Actually what I find totally hypocritical is 44 telling the american people this is a mandate like auto insurance not a tax, then arguing before supreme court just the opposite. Man is a huge hypocrite.
    Jul 16, 2015. 10:40 PM | 2 Likes Like |Link to Comment
  • Zogenix: Promising Small Cap Biotech Is Breaking Out [View article]
    My rules are to take 10% of original share based off after 50% gain, 20% after double and last 20% if it triples. That way you have guaranteed gain and half of original stake riding on the 'house's money', not a bad feeling.
    Jul 16, 2015. 02:44 PM | 1 Like Like |Link to Comment
COMMENTS STATS
11,468 Comments
12,790 Likes